Human papillomavirus vaccines: WHO position paper, October 2014

Wkly Epidemiol Rec. 2014 Oct 24;89(43):465-91.
[Article in En, French]
No abstract available

MeSH terms

  • Age Factors
  • Anus Neoplasms / virology
  • Cervix Uteri / virology
  • Cost-Benefit Analysis
  • Drug Storage / standards
  • Female
  • Humans
  • Immunization Schedule
  • Immunocompromised Host
  • Male
  • Papillomaviridae / classification
  • Papillomaviridae / immunology*
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / immunology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Infections / therapy
  • Papillomavirus Vaccines / adverse effects
  • Papillomavirus Vaccines / immunology
  • Papillomavirus Vaccines / therapeutic use*
  • Precancerous Conditions / therapy
  • Sex Distribution
  • Urogenital Neoplasms / virology
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / virology
  • Warts / immunology
  • Warts / prevention & control
  • World Health Organization*

Substances

  • Papillomavirus Vaccines